Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Lamb Weston to build $250m french fry processing facility in China Lamb Weston said that it will construct a new french fry processing facility in China with an investment… bySrinathMarch 28, 2021
